Starbucks’ revenue rose 19 percent to $8.1 billion from October to December as same-store sales in the US went up 18 percent on-year to off-set same-store sales in China that fell 14 percent partly due to continuing lockdowns
The company said more US customers were visiting at all times of the day and spending more per visit.
Wall Street’s forecast for revenue of $7.89 billion, according to analysts polled by FactSet.
While overall same-store sales growth of 13 percent was in line with expectations, Starbucks’ earnings fell short of forecasts due to inflation, continuing pandemic-related costs, and rising labor costs.
The Seattle-based coffee giant reported adjusted earnings of 72 cents per share, below the 80 cents analysts were forecasting.
Starbucks shares fell 5% in after-hours trading.


South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Disaster or digital spectacle? The dangers of using floods to create social media content
Canada’s local food system faces major roadblocks without urgent policy changes
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Thailand Inflation Remains Negative for 10th Straight Month in January
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Why a ‘rip-off’ degree might be worth the money after all – research study
Why financial hardship is more likely if you’re disabled or sick
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



